
Jan 6 (Reuters) - BillionToOne Inc BLLN.O:
BILLIONTOONE ANNOUNCES SELECTION OF NORTHSTAR SELECT® AS THE NEW LIQUID BIOPSY TEST FOR LC-SCRUM-TRY CLINICAL STUDY AT NATIONAL CANCER CENTER HOSPITAL EAST
BILLIONTOONE- ULTRA-SENSITIVE LIQUID BIOPSY EXPANDING PRECISION MEDICINE ACCESS IN JAPAN WITH TREATMENT-RESISTANT NON-SMALL CELL LUNG CANCER